BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$344M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$266M |
| 3 |
Motorola Solutions
MSI
|
+$224M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$222M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$210M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$235M |
| 2 |
Alibaba
BABA
|
+$199M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$195M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$132M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$122M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.41% |
| 2 | Financials | 6.99% |
| 3 | Consumer Discretionary | 5.47% |
| 4 | Healthcare | 5.09% |
| 5 | Industrials | 4.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
CALL
MGIC Investment
MTG
$6.29B
| $252K | ﹤0.01% |
+200
| New | +$2.58K |
|
2502
BGC Group
BGC
$5.12B
| $251K | ﹤0.01% |
45,718
+24,067
| +111% | +$129K |
|
|
SRG
2503
Seritage Growth Properties
SRG
$131M
| $251K | ﹤0.01% |
5,912
-57
| -1% | -$2.34K |
|
2504
Amphastar Pharmaceuticals
AMPH
$858M
| $251K | ﹤0.01% |
12,666
+8,702
| +220% | +$181K |
|
2505
Artisan Partners
APAM
$2.97B
| $251K | ﹤0.01% |
8,893
+390
| +5% | +$10.9K |
|
2506
Huron Consulting
HURN
$2.47B
| $251K | ﹤0.01% |
4,085
-484
| -11% | -$28.3K |
|
2507
Wabash National
WNC
$507M
| $250K | ﹤0.01% |
17,249
-1,473
| -8% | -$21.8K |
|
2508
Green Dot
GDOT
$766M
| $250K | ﹤0.01% |
9,909
+3,381
| +52% | +$125K |
|
|
ILPT
2509
Industrial Logistics Properties Trust
ILPT
$611M
| $250K | ﹤0.01% |
11,761
-772
| -6% | -$16.5K |
|
2510
FormFactor
FORM
$10.3B
| $250K | ﹤0.01% |
13,404
-544
| -4% | -$9.3K |
|
2511
Stride
LRN
$3.27B
| $250K | ﹤0.01% |
9,456
+983
| +12% | +$28.2K |
|
2512
Apogee Enterprises
APOG
$897M
| $249K | ﹤0.01% |
6,399
+534
| +9% | +$21.1K |
|
2513
Corcept Therapeutics
CORT
$12.1B
| $249K | ﹤0.01% |
17,629
-31,187
| -64% | -$383K |
|
|
CTB
2514
DELISTED
Cooper Tire & Rubber Co.
CTB
| $249K | ﹤0.01% |
9,529
-3,350
| -26% | -$89K |
|
2515
Kosmos Energy
KOS
$1.51B
| $249K | ﹤0.01% |
39,853
-1,015,993
| -96% | -$6.24M |
|
|
ENDP
2516
DELISTED
Endo International plc
ENDP
| $247K | ﹤0.01% |
77,003
+47,328
| +159% | +$153K |
|
2517
AAR Corp
AIR
$5.96B
| $247K | ﹤0.01% |
5,989
+1,592
| +36% | +$66.9K |
|
2518
Kite Realty
KRG
$5.27B
| $246K | ﹤0.01% |
15,221
-1,798
| -11% | -$27.6K |
|
2519
Supernus Pharmaceuticals
SUPN
$2.74B
| $246K | ﹤0.01% |
8,944
+2,367
| +36% | +$70.1K |
|
|
EGOV
2520
DELISTED
NIC Inc
EGOV
| $245K | ﹤0.01% |
11,882
+1,851
| +18% | +$36.2K |
|
2521
Bank of Montreal
BMO
$129B
| $245K | ﹤0.01% |
3,326
| – | – |
|
2522
Archrock
AROC
$5.84B
| $245K | ﹤0.01% |
24,583
-571
| -2% | -$5.7K |
|
|
AMWD
2523
DELISTED
American Woodmark
AMWD
| $245K | ﹤0.01% |
2,756
+1,045
| +61% | +$86.3K |
|
|
BBT
2524
Beacon Financial Corp
BBT
$2.71B
| $245K | ﹤0.01% |
8,364
+2,357
| +39% | +$71.7K |
|
2525
Newmark Group
NMRK
$2.68B
| $245K | ﹤0.01% |
27,006
+7,537
| +39% | +$70K |
|
Similar funds
BNP Paribas Financial Markets's Q3 2019 Portfolio in Review
As of Q3 2019, BNP Paribas Financial Markets held 4,631 positions worth $56.3B, up 12% from $50.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BNP Paribas Financial Markets deployed $1.76B of net new capital in Q3 2019, opening 103 new positions and adding to 2,522 existing holdings. Its largest new stake was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, down from 8.6% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $235M trimmed.
- BNP Paribas Financial Markets's largest Q3 2019 buy was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.
- BNP Paribas Financial Markets added most to Visa in Q3 2019, an estimated $344M increase.
- BNP Paribas Financial Markets's biggest Q3 2019 reduction was Apple, cutting an estimated $235M.
- BNP Paribas Financial Markets fully exited Anadarko Petroleum in Q3 2019, selling an estimated $122M.
- BNP Paribas Financial Markets's ten largest holdings make up 15% of its $56.3B portfolio in Q3 2019.
- BNP Paribas Financial Markets opened 103 new positions and closed 116 in Q3 2019.
- BNP Paribas Financial Markets's portfolio value rose 12% quarter-over-quarter to $56.3B.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2019, filed 7 Nov 2019.